Literature DB >> 20076870

[A randomized comparison of two vaginal procedures for the treatment of uterine prolapse using polypropylene mesh: hysteropexy versus hysterectomy].

Silvia Carramão1, Antonio Pedro Flores Auge, Aparecida Maria Pacetta, Eliana Duarte, Paulo Ayrosa, Nucélio Lml Lemos, Tsutomu Aoki.   

Abstract

OBJECTIVES: To compare surgical morbidity and time, as well as anatomical outcomes between vaginal histerectomy and uterine preservation in the treatment of uterine prolapse using a mesh kit (Nazca).
METHODS: Randomized controled trial with 31 women with uterine prolapse POP-Q stage 3 or 4 pelvic organ prolapse who underwent vaginal surgery using tipe I polypropilene mesh (Nazca). They were randomized in two groups: group HV: hysterectomy and pelvic reconstruction floor with mesh (n=15); group HP: hysteropexy and pelvic reconstruction floor with mesh (n=16). Race, miccional urgency, intestinal constipation, sacral pain were assessed as well as the amount of bleeding and time of operation.
RESULTS: Median follow-up was nine months on both groups. No difference was observed on complication rates and functional outcomes. Operation time was 120 minutes on group HV, versus 58.9 minutes on group HP (X(2) = 17.613*, p < 0.001 ) and intraoperative blood loss was 120 mL on group HV versus 20 mL on group HP (X(2) = 19.425*; p < 0.001). There was no differences in relationship to anatomical cure rates. Objective success rate was 86.67% to group HV and 75% to group HP (p=0,667) at nine months of follow-up. The anatomical results were similar between the two groups.
CONCLUSION: The anatomic results between histeropexy and hysterectomy were similar. However, surgical time and blood loss were greater in group with histerectomies. The erosion rate were also similar. Vaginal surgery using mesh is an effective procedure for pelvic organ prolapse.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20076870     DOI: 10.1590/s0100-69912009000100012

Source DB:  PubMed          Journal:  Rev Col Bras Cir        ISSN: 0100-6991


  8 in total

1.  Laparoscopic sacral hysteropexy versus laparoscopic sacrocolpopexy with hysterectomy for pelvic organ prolapse.

Authors:  Ke Pan; Lili Cao; Nicholas A Ryan; Yanzhou Wang; Huicheng Xu
Journal:  Int Urogynecol J       Date:  2015-07-16       Impact factor: 2.894

Review 2.  Hysteropreservation versus hysterectomy in the surgical treatment of uterine prolapse: systematic review and meta-analysis.

Authors:  Sofia Andrade de Oliveira; Marcelo C M Fonseca; Maria A T Bortolini; Manoel J B C Girão; Matheus T Roque; Rodrigo A Castro
Journal:  Int Urogynecol J       Date:  2017-08-05       Impact factor: 2.894

Review 3.  Native Tissue Repairs for Pelvic Organ Prolapse.

Authors:  Justin Houman; James M Weinberger; Karyn S Eilber
Journal:  Curr Urol Rep       Date:  2017-01       Impact factor: 3.092

4.  Surgical interventions for uterine prolapse and for vault prolapse: the two VUE RCTs.

Authors:  Christine Hemming; Lynda Constable; Beatriz Goulao; Mary Kilonzo; Dwayne Boyers; Andrew Elders; Kevin Cooper; Anthony Smith; Robert Freeman; Suzanne Breeman; Alison McDonald; Suzanne Hagen; Isobel Montgomery; John Norrie; Cathryn Glazener
Journal:  Health Technol Assess       Date:  2020-03       Impact factor: 4.014

Review 5.  Role of Hysteropexy in the Management of Pelvic Organ Prolapse.

Authors:  Zoe S Gan; Daniel S Roberson; Ariana L Smith
Journal:  Curr Urol Rep       Date:  2022-07-05       Impact factor: 2.862

6.  Effect of pregnancy on uterine-sparing pelvic organ prolapse repair.

Authors:  Tejumola M Adegoke; Olivera Vragovic; Christina Deck Yarrington; Jean-Robert Larrieux
Journal:  Int Urogynecol J       Date:  2019-12-11       Impact factor: 2.894

7.  Laparoscopic hysterosacropexy in case of total uterus prolapse - case report.

Authors:  Paweł Szymanowski; Wioletta Katarzyna Szepieniec; Paweł Gruszecki; Isabel Netzer
Journal:  Int J Surg Case Rep       Date:  2018-10-29

8.  Comparison of UpholdTM Vaginal Mesh Procedure with Hysterectomy or Uterine Preservation for the Treatment of Pelvic Organ Prolapse.

Authors:  Chin-Ru Ker; Kun-Ling Lin; Zi-Xi Loo; Yung-Shun Juan; Cheng-Yu Long
Journal:  Sci Rep       Date:  2018-06-21       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.